Helicoverpa zea isolate HzStark_Cry1AcR chromosome 16, ilHelZeax1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Noctuoidea; Noctuidae; Heliothinae; Helicoverpa.
REFSEQ INFORMATION: The reference sequence is identical to\nCM040218.1.\nAssembly name: ilHelZeax1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the United States Department of\nAgriculture on 2022/03/18. The original whole-genome shotgun\nproject has the accession JAKYJW000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: United States Department of Agriculture\nAssembly Date :: 31-DEC-2021\nAssembly Method :: FALCON v. 1.8.1; FALCON-Unzip v. 1.3.7;\n purge_dups v. 1.2.5; bwa-mem v. 2.2.1;\n Juicebox v. 1.11.08; Arrow gcpp v. 2.0.2;\n FreeBayes v. 1.0.2; Merqury v. 1.1\nAssembly Name :: ilHelZeax1.1\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 144x\nSequencing Technology :: PacBio Sequel II CLR; Illumina NovaSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Helicoverpa zea Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
laboratory colony at USDA ARS Southern Insect Management Unit, Stoneville, MS
USDA-ARS Genetics and Sustainability Agricultural Research Unit, Starkville, MS, USA
Derived by automated computational analysis using gene prediction method: Gnomon.
ankyrin repeat and zinc finger domain-containing protein 1-like
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
28S ribosomal protein S18a, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
hairy/enhancer-of-split related with YRPW motif protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
arginine-glutamic acid dipeptide repeats protein
von Willebrand factor A domain-containing protein 8
calmodulin-A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
calmodulin-A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calmodulin-A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
membrane-bound alkaline phosphatase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 58% coverage of the annotated genomic feature by RNAseq alignments
atrial natriuretic peptide receptor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
palmitoyltransferase ZDHHC8, transcript variant X1
palmitoyltransferase ZDHHC8, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 homolog
CBP80/20-dependent translation initiation factor, transcript variant X1
CBP80/20-dependent translation initiation factor, transcript variant X2
CBP80/20-dependent translation initiation factor isoform X1
CBP80/20-dependent translation initiation factor isoform X2
CBP80/20-dependent translation initiation factor, transcript variant X3
CBP80/20-dependent translation initiation factor isoform X3
uncharacterized LOC124637506, transcript variant X1
uncharacterized LOC124637506, transcript variant X2
uncharacterized LOC124637506, transcript variant X4
uncharacterized LOC124637506, transcript variant X3
uncharacterized protein LOC124637506 isoform X2
uncharacterized protein LOC124637506 isoform X3
uncharacterized protein LOC124637506 isoform X1
formin-like protein, transcript variant X3
formin-like protein, transcript variant X1
formin-like protein, transcript variant X2
phosphopantothenoylcysteine decarboxylase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC124637321, transcript variant X2
uncharacterized LOC124637321, transcript variant X1
uncharacterized protein LOC124637321 isoform X2
uncharacterized protein LOC124637321 isoform X1
cyclin-dependent kinase 12, transcript variant X7
cyclin-dependent kinase 12, transcript variant X2
cyclin-dependent kinase 12, transcript variant X1
cyclin-dependent kinase 12, transcript variant X4
cyclin-dependent kinase 12, transcript variant X5
cyclin-dependent kinase 12, transcript variant X6
cyclin-dependent kinase 12, transcript variant X3
unconventional myosin IC, transcript variant X1
unconventional myosin IC, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PHD finger-like domain-containing protein 5A
probable ATP-dependent RNA helicase DDX47
CCR4-NOT transcription complex subunit 3, transcript variant X5
CCR4-NOT transcription complex subunit 3, transcript variant X2
CCR4-NOT transcription complex subunit 3, transcript variant X3
CCR4-NOT transcription complex subunit 3, transcript variant X1
CCR4-NOT transcription complex subunit 3, transcript variant X6
CCR4-NOT transcription complex subunit 3, transcript variant X4
CCR4-NOT transcription complex subunit 3 isoform X6
CCR4-NOT transcription complex subunit 3 isoform X4
CCR4-NOT transcription complex subunit 3 isoform X5
CCR4-NOT transcription complex subunit 3 isoform X2
CCR4-NOT transcription complex subunit 3 isoform X3
CCR4-NOT transcription complex subunit 3 isoform X1
lutropin-choriogonadotropic hormone receptor-like
AN1-type zinc finger protein 1-like, transcript variant X1
AN1-type zinc finger protein 1-like, transcript variant X2
AN1-type zinc finger protein 1-like isoform X2
AN1-type zinc finger protein 1-like isoform X1
valine--tRNA ligase, transcript variant X2
valine--tRNA ligase, transcript variant X1
valine--tRNA ligase, transcript variant X3
transformer-2 protein homolog alpha, transcript variant X1
transformer-2 protein homolog alpha, transcript variant X3
transformer-2 protein homolog alpha, transcript variant X2
transformer-2 protein homolog alpha, transcript variant X4
transformer-2 protein homolog alpha isoform X2
transformer-2 protein homolog alpha isoform X3
transformer-2 protein homolog alpha isoform X1
transformer-2 protein homolog alpha isoform X4
probable RNA 3'-terminal phosphate cyclase-like protein
kinase suppressor of Ras 1, transcript variant X2
kinase suppressor of Ras 1, transcript variant X3
kinase suppressor of Ras 1, transcript variant X1
uncharacterized LOC124637361, transcript variant X2
uncharacterized LOC124637361, transcript variant X1
uncharacterized LOC124637361, transcript variant X3
uncharacterized protein LOC124637361 isoform X3
uncharacterized protein LOC124637361 isoform X2
uncharacterized protein LOC124637361 isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase isoform X3
neurofilament heavy polypeptide isoform X4
neurofilament heavy polypeptide isoform X3
neurofilament heavy polypeptide isoform X2
acyl carrier protein, mitochondrial, transcript variant X1
acyl carrier protein, mitochondrial, transcript variant X2
acyl carrier protein, mitochondrial isoform X1
acyl carrier protein, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SPRY domain-containing SOCS box protein 3-like, transcript variant X1
SPRY domain-containing SOCS box protein 3-like, transcript variant X2
SPRY domain-containing SOCS box protein 3-like isoform X1
SPRY domain-containing SOCS box protein 3-like isoform X2
complement component 1 Q subcomponent-binding protein, mitochondrial, transcript variant X1
complement component 1 Q subcomponent-binding protein, mitochondrial, transcript variant X2
complement component 1 Q subcomponent-binding protein, mitochondrial isoform X2
complement component 1 Q subcomponent-binding protein, mitochondrial isoform X1
rRNA N6-adenosine-methyltransferase ZCCHC4
protein lin-37 homolog, transcript variant X3
protein lin-37 homolog, transcript variant X1
protein lin-37 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC124637738, transcript variant X2
uncharacterized LOC124637738, transcript variant X3
uncharacterized LOC124637738, transcript variant X1
uncharacterized protein LOC124637738 isoform X1
uncharacterized protein LOC124637738 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X3
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5 isoform X1
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
probable ATP-dependent RNA helicase DDX52
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
protein real-time, transcript variant X1
protein real-time, transcript variant X2
ubiquitin-like modifier-activating enzyme 1
uncharacterized LOC124637831, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC124637831, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124637831, transcript variant X4
uncharacterized protein LOC124637831 isoform X3
uncharacterized protein LOC124637831 isoform X2
uncharacterized protein LOC124637831 isoform X4
uncharacterized LOC124637831, transcript variant X1
uncharacterized protein LOC124637831 isoform X1
protein-S-isoprenylcysteine O-methyltransferase
rab GTPase-binding effector protein 1, transcript variant X1
rab GTPase-binding effector protein 1, transcript variant X2
rab GTPase-binding effector protein 1, transcript variant X3
rab GTPase-binding effector protein 1 isoform X1
rab GTPase-binding effector protein 1 isoform X2
structural maintenance of chromosomes protein 1A, transcript variant X1
structural maintenance of chromosomes protein 1A isoform X1
structural maintenance of chromosomes protein 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
structural maintenance of chromosomes protein 1A isoform X2
histone deacetylase 4, transcript variant X12
histone deacetylase 4, transcript variant X13
histone deacetylase 4, transcript variant X11
histone deacetylase 4, transcript variant X6
histone deacetylase 4, transcript variant X9
histone deacetylase 4, transcript variant X4
histone deacetylase 4, transcript variant X8
histone deacetylase 4, transcript variant X5
histone deacetylase 4, transcript variant X1
histone deacetylase 4, transcript variant X2
histone deacetylase 4, transcript variant X3
histone deacetylase 4, transcript variant X7
histone deacetylase 4, transcript variant X10
GATOR complex protein MIOS, transcript variant X2
GATOR complex protein MIOS, transcript variant X1
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ras-related protein Ral-a, transcript variant X6
ras-related protein Ral-a, transcript variant X4
ras-related protein Ral-a, transcript variant X2
ras-related protein Ral-a, transcript variant X1
ras-related protein Ral-a, transcript variant X5
ras-related protein Ral-a, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 30 homolog
eukaryotic translation initiation factor 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124637665, transcript variant X5
uncharacterized LOC124637665, transcript variant X1
uncharacterized LOC124637665, transcript variant X2
uncharacterized LOC124637665, transcript variant X6
uncharacterized LOC124637665, transcript variant X4
uncharacterized LOC124637665, transcript variant X3
uncharacterized protein LOC124637665 isoform X3
uncharacterized protein LOC124637665 isoform X2
uncharacterized protein LOC124637665 isoform X1
double-stranded RNA-specific editase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
double-stranded RNA-specific editase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
double-stranded RNA-specific editase 1-like isoform X1
double-stranded RNA-specific editase 1-like isoform X3
double-stranded RNA-specific editase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
double-stranded RNA-specific editase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
double-stranded RNA-specific editase 1-like isoform X2
double-stranded RNA-specific editase 1-like isoform X4
double-stranded RNA-specific editase 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
double-stranded RNA-specific editase 1-like isoform X5
ras-related protein M-Ras-like, transcript variant X1
ras-related protein M-Ras-like isoform X1
ras-related protein M-Ras-like, transcript variant X2
ras-related protein M-Ras-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
calcitonin gene-related peptide type 1 receptor, transcript variant X3
calcitonin gene-related peptide type 1 receptor, transcript variant X2
calcitonin gene-related peptide type 1 receptor, transcript variant X1
calcitonin gene-related peptide type 1 receptor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
calcitonin gene-related peptide type 1 receptor isoform X1
calcitonin gene-related peptide type 1 receptor isoform X2
calcitonin gene-related peptide type 1 receptor, transcript variant X5
calcitonin gene-related peptide type 1 receptor isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein regulatory complex protein 10-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
pre-mRNA-processing-splicing factor 8, transcript variant X2
pre-mRNA-processing-splicing factor 8, transcript variant X1
pre-mRNA-processing-splicing factor 8 isoform X2
pre-mRNA-processing-splicing factor 8 isoform X1
mutS protein homolog 4-like, transcript variant X1
mutS protein homolog 4-like, transcript variant X2
phosphoserine phosphatase, transcript variant X1
phosphoserine phosphatase, transcript variant X5
phosphoserine phosphatase, transcript variant X4
phosphoserine phosphatase, transcript variant X6
phosphoserine phosphatase, transcript variant X2
phosphoserine phosphatase, transcript variant X3
rho GTPase-activating protein gacII-like, transcript variant X2
rho GTPase-activating protein gacII-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
rho GTPase-activating protein gacII-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho GTPase-activating protein gacII-like isoform X1
rho GTPase-activating protein gacII-like isoform X2
UNC93-like protein, transcript variant X6
UNC93-like protein, transcript variant X4
UNC93-like protein, transcript variant X2
UNC93-like protein, transcript variant X3
UNC93-like protein, transcript variant X1
UNC93-like protein, transcript variant X5
AH receptor-interacting protein-like, transcript variant X2
AH receptor-interacting protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
cold shock domain-containing protein CG9705
huntingtin-interacting protein 1, transcript variant X6
huntingtin-interacting protein 1, transcript variant X1
huntingtin-interacting protein 1, transcript variant X2
huntingtin-interacting protein 1, transcript variant X5
huntingtin-interacting protein 1, transcript variant X7
huntingtin-interacting protein 1, transcript variant X9
huntingtin-interacting protein 1, transcript variant X8
huntingtin-interacting protein 1, transcript variant X3
huntingtin-interacting protein 1, transcript variant X4
huntingtin-interacting protein 1 isoform X6
huntingtin-interacting protein 1 isoform X5
huntingtin-interacting protein 1 isoform X4
huntingtin-interacting protein 1 isoform X3
huntingtin-interacting protein 1 isoform X1
huntingtin-interacting protein 1 isoform X2
target of rapamycin complex subunit lst8, transcript variant X3
target of rapamycin complex subunit lst8, transcript variant X2
target of rapamycin complex subunit lst8, transcript variant X1
target of rapamycin complex subunit lst8
ADP-ribosylation factor-binding protein GGA2, transcript variant X2
ADP-ribosylation factor-binding protein GGA2, transcript variant X1
ADP-ribosylation factor-binding protein GGA2 isoform X2
ADP-ribosylation factor-binding protein GGA2 isoform X1
inositol hexakisphosphate kinase 2, transcript variant X2
inositol hexakisphosphate kinase 2 isoform X2
inositol hexakisphosphate kinase 2, transcript variant X1
inositol hexakisphosphate kinase 2 isoform X1
inositol hexakisphosphate kinase 2, transcript variant X3
inositol hexakisphosphate kinase 2, transcript variant X4
inositol hexakisphosphate kinase 2 isoform X3
transmembrane protein 203-like, transcript variant X2
transmembrane protein 203-like, transcript variant X1
transmembrane protein 203-like isoform X2
ribonuclease P protein subunit p20-like isoform X1
uncharacterized LOC124637846, transcript variant X1
uncharacterized LOC124637846, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 36% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 64% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
glutathione hydrolase 1 proenzyme-like, transcript variant X5
glutathione hydrolase 1 proenzyme-like isoform X2
glutathione hydrolase 1 proenzyme-like, transcript variant X1
glutathione hydrolase 1 proenzyme-like, transcript variant X3
glutathione hydrolase 1 proenzyme-like, transcript variant X2
glutathione hydrolase 1 proenzyme-like, transcript variant X4
glutathione hydrolase 1 proenzyme-like isoform X1
sec1 family domain-containing protein 2-like
cytochrome c oxidase subunit 6A1, mitochondrial-like
autophagy-related protein 101, transcript variant X1
serine/threonine-protein kinase S6KL isoform X1
translation initiation factor IF-2-like, transcript variant X2
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like isoform X1
translation initiation factor IF-2-like isoform X2
autophagy-related protein 101, transcript variant X3
autophagy-related protein 101 isoform X3
autophagy-related protein 101, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
serine/threonine-protein kinase S6KL isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
bifunctional coenzyme A synthase, transcript variant X2
bifunctional coenzyme A synthase, transcript variant X3
bifunctional coenzyme A synthase, transcript variant X1
bifunctional coenzyme A synthase isoform X1
bifunctional coenzyme A synthase isoform X2
G-protein coupled receptor Mth2-like, transcript variant X2
G-protein coupled receptor Mth2-like, transcript variant X1
G-protein coupled receptor Mth2-like, transcript variant X3
G-protein coupled receptor Mth2-like, transcript variant X4
G-protein coupled receptor Mth2-like isoform X3
G-protein coupled receptor Mth2-like isoform X2
G-protein coupled receptor Mth2-like isoform X1
ATP-dependent translocase ABCB1-like, transcript variant X2
ATP-dependent translocase ABCB1-like, transcript variant X1
ATP-dependent translocase ABCB1-like isoform X2
ATP-dependent translocase ABCB1-like isoform X1
prostaglandin reductase 1-like, transcript variant X2
prostaglandin reductase 1-like, transcript variant X1
prostaglandin reductase 1-like isoform X1
prostaglandin reductase 1-like isoform X2
uncharacterized LOC124637594, transcript variant X2
uncharacterized LOC124637594, transcript variant X1
methylated-DNA--protein-cysteine methyltransferase, inducible
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: methylated-DNA--protein-cysteine methyltransferase, inducible
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X2
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X1
MATH and LRR domain-containing protein PFE0570w-like
transmembrane protein 120 homolog, transcript variant X3
transmembrane protein 120 homolog, transcript variant X1
transmembrane protein 120 homolog, transcript variant X2
transmembrane protein 120 homolog isoform X2
transmembrane protein 120 homolog isoform X3
transmembrane protein 120 homolog isoform X1
transmembrane protein 120 homolog, transcript variant X4
transmembrane protein 120 homolog isoform X4
lissencephaly-1 homolog, transcript variant X1
lissencephaly-1 homolog, transcript variant X2
uncharacterized LOC124637629, transcript variant X2
uncharacterized LOC124637629, transcript variant X1
zinc finger HIT domain-containing protein 3
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
matrix metalloproteinase-14-like, transcript variant X1
matrix metalloproteinase-14-like, transcript variant X2
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cytochrome c oxidase assembly protein COX19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
notchless protein homolog 1, transcript variant X1
notchless protein homolog 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
active breakpoint cluster region-related protein, transcript variant X1
active breakpoint cluster region-related protein, transcript variant X2
active breakpoint cluster region-related protein, transcript variant X4
active breakpoint cluster region-related protein, transcript variant X3
active breakpoint cluster region-related protein isoform X1
active breakpoint cluster region-related protein isoform X3
active breakpoint cluster region-related protein isoform X2
active breakpoint cluster region-related protein isoform X4
cysteine-rich with EGF-like domain protein 2
cytochrome P450 315a1, mitochondrial, transcript variant X2
cytochrome P450 315a1, mitochondrial, transcript variant X1
cytochrome P450 315a1, mitochondrial isoform X1
cytochrome P450 315a1, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome P450 315a1, mitochondrial isoform X2
26S proteasome non-ATPase regulatory subunit 2
uncharacterized LOC124637610, transcript variant X2
uncharacterized LOC124637610, transcript variant X1
uncharacterized protein LOC124637610 isoform X1
uncharacterized protein LOC124637610 isoform X2
uncharacterized LOC124637611, transcript variant X2
uncharacterized LOC124637611, transcript variant X1
serine/threonine-protein kinase unc-51, transcript variant X1
serine/threonine-protein kinase unc-51, transcript variant X2
serine/threonine-protein kinase unc-51 isoform X2
serine/threonine-protein kinase unc-51 isoform X1
carboxypeptidase D, transcript variant X1
carboxypeptidase D, transcript variant X2
replication factor C subunit 5, transcript variant X1
replication factor C subunit 5, transcript variant X2
replication factor C subunit 5 isoform X2
replication factor C subunit 5 isoform X1
cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase
high mobility group protein 20A, transcript variant X1
high mobility group protein 20A, transcript variant X2
high mobility group protein 20A isoform X1
high mobility group protein 20A isoform X2
histone RNA hairpin-binding protein, transcript variant X1
histone RNA hairpin-binding protein, transcript variant X2
ADP-ribose pyrophosphatase, mitochondrial
translocon-associated protein subunit gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
lysosomal-associated transmembrane protein 4A, transcript variant X2
lysosomal-associated transmembrane protein 4A, transcript variant X5
lysosomal-associated transmembrane protein 4A, transcript variant X3
lysosomal-associated transmembrane protein 4A, transcript variant X1
lysosomal-associated transmembrane protein 4A, transcript variant X4
lysosomal-associated transmembrane protein 4A isoform X3
lysosomal-associated transmembrane protein 4A isoform X2
lysosomal-associated transmembrane protein 4A isoform X1
uncharacterized LOC124637621, transcript variant X5
uncharacterized LOC124637621, transcript variant X4
uncharacterized LOC124637621, transcript variant X2
uncharacterized LOC124637621, transcript variant X3
uncharacterized LOC124637621, transcript variant X1
ragulator complex protein LAMTOR4 homolog
vacuolar fusion protein CCZ1 homolog, transcript variant X2
vacuolar fusion protein CCZ1 homolog, transcript variant X1
vacuolar fusion protein CCZ1 homolog isoform X1
vacuolar fusion protein CCZ1 homolog isoform X2
EF-hand domain-containing family member C2-like
dual oxidase maturation factor 1, transcript variant X1
dual oxidase maturation factor 1, transcript variant X3
dual oxidase maturation factor 1, transcript variant X2
dual oxidase maturation factor 1 isoform X1
dual oxidase maturation factor 1 isoform X2
transcription factor 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transcription factor 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
integrin alpha-PS1, transcript variant X2
integrin alpha-PS1, transcript variant X1
uncharacterized LOC124637489, transcript variant X1
uncharacterized LOC124637489, transcript variant X2
uncharacterized LOC124637489, transcript variant X3
uncharacterized protein LOC124637489 isoform X1
uncharacterized protein LOC124637489 isoform X2
peptidyl-prolyl cis-trans isomerase G-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATP-binding cassette sub-family B member 6, transcript variant X1
ATP-binding cassette sub-family B member 6, transcript variant X2
ATP-binding cassette sub-family B member 6
G protein-coupled receptor kinase 1, transcript variant X1
G protein-coupled receptor kinase 1, transcript variant X2
G protein-coupled receptor kinase 1 isoform X1
G protein-coupled receptor kinase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124637392, transcript variant X2
uncharacterized LOC124637392, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
intraflagellar transport protein 22 homolog, transcript variant X2
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
intraflagellar transport protein 22 homolog, transcript variant X1
intraflagellar transport protein 22 homolog isoform X1
intraflagellar transport protein 22 homolog isoform X2
protein suppressor of sable, transcript variant X2
protein suppressor of sable, transcript variant X1
protein FAM117B-like, transcript variant X1
protein FAM117B-like, transcript variant X2
protein FAM117B-like, transcript variant X3
glucocorticoid-induced transcript 1 protein-like isoform X1
DNA-directed RNA polymerase II subunit Rpb4, transcript variant X2
DNA-directed RNA polymerase II subunit Rpb4, transcript variant X1
DNA-directed RNA polymerase II subunit Rpb4
cyclin-dependent kinase 2-interacting protein-like
uncharacterized LOC124637371, transcript variant X4
uncharacterized protein LOC124637371 isoform X4
uncharacterized LOC124637371, transcript variant X1
uncharacterized protein LOC124637371 isoform X1
uncharacterized LOC124637371, transcript variant X2
uncharacterized protein LOC124637371 isoform X2
uncharacterized LOC124637371, transcript variant X3
uncharacterized protein LOC124637371 isoform X3
uncharacterized LOC124637371, transcript variant X5
uncharacterized protein LOC124637371 isoform X5
uncharacterized LOC124637371, transcript variant X6
uncharacterized protein LOC124637371 isoform X6
ubiquitin carboxyl-terminal hydrolase calypso
clustered mitochondria protein homolog, transcript variant X2
clustered mitochondria protein homolog, transcript variant X1
clustered mitochondria protein homolog isoform X2
clustered mitochondria protein homolog isoform X1
trafficking protein particle complex subunit 13
cytoplasmic phosphatidylinositol transfer protein 1
trypsin delta-like, transcript variant X1
trypsin delta-like, transcript variant X2
calcium-binding protein E63-1, transcript variant X2
calcium-binding protein E63-1 isoform X2
calcium-binding protein E63-1, transcript variant X4
calcium-binding protein E63-1, transcript variant X5
calcium-binding protein E63-1, transcript variant X3
calcium-binding protein E63-1 isoform X3
calcium-binding protein E63-1 isoform X4
calcium-binding protein E63-1, transcript variant X1
calcium-binding protein E63-1 isoform X1
calcium-binding protein E63-1, transcript variant X6
calcium-binding protein E63-1 isoform X5
calcium-binding protein E63-1, transcript variant X7
calcium-binding protein E63-1 isoform X6
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6-like
putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase
cytochrome P450 9e2-like, transcript variant X1
cytochrome P450 9e2-like, transcript variant X2
tRNA (cytosine(72)-C(5))-methyltransferase NSUN6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
serine--pyruvate aminotransferase, mitochondrial
serine--pyruvate aminotransferase, mitochondrial-like, transcript variant X2
serine--pyruvate aminotransferase, mitochondrial-like, transcript variant X3
serine--pyruvate aminotransferase, mitochondrial-like, transcript variant X1
serine--pyruvate aminotransferase, mitochondrial-like
uncharacterized LOC124637850, transcript variant X1
uncharacterized LOC124637850, transcript variant X2
uncharacterized LOC124637850, transcript variant X3
uncharacterized LOC124637850, transcript variant X4
uncharacterized protein LOC124637850 isoform X2
uncharacterized protein LOC124637850 isoform X3
uncharacterized protein LOC124637850 isoform X1
uncharacterized LOC124637719, transcript variant X3
uncharacterized LOC124637719, transcript variant X1
uncharacterized LOC124637719, transcript variant X2
uncharacterized protein LOC124637719 isoform X1
uncharacterized protein LOC124637719 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
rho guanine nucleotide exchange factor 10-like protein, transcript variant X3
rho guanine nucleotide exchange factor 10-like protein isoform X3
rho guanine nucleotide exchange factor 10-like protein, transcript variant X2
rho guanine nucleotide exchange factor 10-like protein isoform X2
rho guanine nucleotide exchange factor 10-like protein, transcript variant X1
rho guanine nucleotide exchange factor 10-like protein isoform X1
rho guanine nucleotide exchange factor 10-like protein, transcript variant X5
rho guanine nucleotide exchange factor 10-like protein isoform X5
rho guanine nucleotide exchange factor 10-like protein, transcript variant X4
rho guanine nucleotide exchange factor 10-like protein isoform X4
coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial-like
transducin beta-like protein 2, transcript variant X4
transducin beta-like protein 2, transcript variant X2
transducin beta-like protein 2, transcript variant X1
transducin beta-like protein 2 isoform X2
transducin beta-like protein 2 isoform X4
transducin beta-like protein 2, transcript variant X3
tripartite motif-containing protein 2-like
cytochrome P450 CYP12A2, transcript variant X1
cytochrome P450 CYP12A2, transcript variant X2
cytochrome P450 CYP12A2, transcript variant X3
protein alan shepard, transcript variant X3
protein alan shepard, transcript variant X2
protein alan shepard, transcript variant X5
protein alan shepard, transcript variant X1
protein alan shepard, transcript variant X6
protein alan shepard, transcript variant X4
protein alan shepard, transcript variant X7
protein alan shepard, transcript variant X8
ribosome biogenesis protein WDR12 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC124637708, transcript variant X1
uncharacterized LOC124637708, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC124637708 isoform X1
uncharacterized protein LOC124637708 isoform X2
cationic amino acid transporter 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cationic amino acid transporter 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cationic amino acid transporter 4 isoform X2
cationic amino acid transporter 4 isoform X1
spindle assembly abnormal protein 6 homolog
ovarian-specific serine/threonine-protein kinase Lok
uncharacterized LOC124637587, transcript variant X2
uncharacterized LOC124637587, transcript variant X1
uncharacterized protein LOC124637587 isoform X2
uncharacterized protein LOC124637587 isoform X1
uncharacterized LOC124637586, transcript variant X1
uncharacterized LOC124637586, transcript variant X2
RNA-binding protein with serine-rich domain 1-A-like, transcript variant X3
RNA-binding protein with serine-rich domain 1-A-like, transcript variant X2
RNA-binding protein with serine-rich domain 1-A-like, transcript variant X1
RNA-binding protein with serine-rich domain 1-A-like
cell cycle checkpoint protein RAD17, transcript variant X2
cell cycle checkpoint protein RAD17, transcript variant X3
cell cycle checkpoint protein RAD17, transcript variant X1
cell cycle checkpoint protein RAD17 isoform X2
cell cycle checkpoint protein RAD17 isoform X3
cell cycle checkpoint protein RAD17 isoform X1
NADH-quinone oxidoreductase subunit B 2-like
fibrosin-1-like protein, transcript variant X12
fibrosin-1-like protein, transcript variant X5
fibrosin-1-like protein, transcript variant X3
fibrosin-1-like protein, transcript variant X1
fibrosin-1-like protein, transcript variant X7
fibrosin-1-like protein, transcript variant X2
fibrosin-1-like protein, transcript variant X6
fibrosin-1-like protein, transcript variant X10
fibrosin-1-like protein, transcript variant X4
fibrosin-1-like protein, transcript variant X8
fibrosin-1-like protein, transcript variant X9
fibrosin-1-like protein, transcript variant X11
fibrosin-1-like protein, transcript variant X13
proline-rich protein 36-like isoform X12
proline-rich protein 36-like isoform X13
vitamin K epoxide reductase complex subunit 1, transcript variant X3
vitamin K epoxide reductase complex subunit 1, transcript variant X2
vitamin K epoxide reductase complex subunit 1, transcript variant X1
vitamin K epoxide reductase complex subunit 1
serine/arginine repetitive matrix protein 1, transcript variant X4
serine/arginine repetitive matrix protein 1, transcript variant X5
serine/arginine repetitive matrix protein 1 isoform X2
serine/arginine repetitive matrix protein 1, transcript variant X1
serine/arginine repetitive matrix protein 1, transcript variant X3
serine/arginine repetitive matrix protein 1, transcript variant X2
serine/arginine repetitive matrix protein 1 isoform X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 13% coverage of the annotated genomic feature by RNAseq alignments
glutaryl-CoA dehydrogenase, mitochondrial
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC124637837, transcript variant X1
uncharacterized LOC124637837, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
putative uncharacterized protein DDB_G0282133
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
replication protein A 70 kDa DNA-binding subunit
transmembrane protein 47, transcript variant X1
transmembrane protein 47, transcript variant X2
transmembrane protein 47, transcript variant X3
uncharacterized protein LOC124637364 isoform X2
conserved oligomeric Golgi complex subunit 8
zinc finger protein 358-like, transcript variant X1
zinc finger protein 358-like, transcript variant X2
zinc finger protein 358-like, transcript variant X3
zinc finger protein 358-like, transcript variant X4
uncharacterized LOC124637353, transcript variant X1
uncharacterized LOC124637353, transcript variant X2
uncharacterized LOC124637352, transcript variant X5
uncharacterized LOC124637352, transcript variant X1
uncharacterized LOC124637352, transcript variant X4
uncharacterized LOC124637352, transcript variant X3
uncharacterized LOC124637352, transcript variant X2
uncharacterized protein LOC124637352 isoform X3
uncharacterized protein LOC124637352 isoform X4
uncharacterized protein LOC124637352 isoform X2
uncharacterized protein LOC124637352 isoform X1
general transcription factor IIH subunit 2
facilitated trehalose transporter Tret1, transcript variant X2
facilitated trehalose transporter Tret1, transcript variant X1
facilitated trehalose transporter Tret1 isoform X2
facilitated trehalose transporter Tret1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124637304, transcript variant X2
uncharacterized LOC124637304, transcript variant X1
mediator of RNA polymerase II transcription subunit 1, transcript variant X2
mediator of RNA polymerase II transcription subunit 1, transcript variant X1
mediator of RNA polymerase II transcription subunit 1 isoform X2
mediator of RNA polymerase II transcription subunit 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
putative phospholipase B-like lamina ancestor, transcript variant X3
putative phospholipase B-like lamina ancestor, transcript variant X1
putative phospholipase B-like lamina ancestor, transcript variant X2
putative phospholipase B-like lamina ancestor isoform X2
putative phospholipase B-like lamina ancestor isoform X1
aryl hydrocarbon receptor nuclear translocator-like protein 2
NFX1-type zinc finger-containing protein 1-like
KRR1 small subunit processome component homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
DNA (cytosine-5)-methyltransferase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 1-like isoform X2
DNA (cytosine-5)-methyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
DNA (cytosine-5)-methyltransferase 1-like isoform X1
DNA (cytosine-5)-methyltransferase PliMCI-like, transcript variant X2
DNA (cytosine-5)-methyltransferase PliMCI-like isoform X2
DNA (cytosine-5)-methyltransferase PliMCI-like, transcript variant X1
DNA (cytosine-5)-methyltransferase PliMCI-like isoform X1
TP53-regulated inhibitor of apoptosis 1-like
uncharacterized LOC124637839, transcript variant X2
uncharacterized protein LOC124637839 isoform X2
uncharacterized LOC124637839, transcript variant X1
uncharacterized protein LOC124637839 isoform X1
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2
uncharacterized LOC124637691, transcript variant X1
uncharacterized LOC124637691, transcript variant X2
signal recognition particle receptor subunit beta
pyridoxine/pyridoxamine 5'-phosphate oxidase-like
histidine protein methyltransferase 1 homolog
proteasome activator complex subunit 3, transcript variant X1
proteasome activator complex subunit 3 isoform X1
proteasome activator complex subunit 3, transcript variant X2
proteasome activator complex subunit 3 isoform X2
coiled-coil domain-containing protein 181-like, transcript variant X2
coiled-coil domain-containing protein 181-like, transcript variant X1
coiled-coil domain-containing protein 181-like
uncharacterized LOC124637287, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC124637287 isoform X2
uncharacterized LOC124637287, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC124637287 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 37% coverage of the annotated genomic feature by RNAseq alignments
malate dehydrogenase, mitochondrial-like
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X3
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X6
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X5
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X4
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X3
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X4
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X1
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X2
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X1
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable ATP-dependent DNA helicase HFM1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
dynein regulatory complex subunit 2-like
inositol polyphosphate 5-phosphatase K-like, transcript variant X1
inositol polyphosphate 5-phosphatase K-like, transcript variant X2
inositol polyphosphate 5-phosphatase K-like, transcript variant X3
inositol polyphosphate 5-phosphatase K-like isoform X1
inositol polyphosphate 5-phosphatase K-like isoform X2
inositol polyphosphate 5-phosphatase K-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 77% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
F-box/LRR-repeat protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
F-box/LRR-repeat protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
alpha-amylase 4N-like, transcript variant X1
alpha-amylase 4N-like, transcript variant X2
alpha-amylase A-like, transcript variant X2
alpha-amylase A-like, transcript variant X1
uncharacterized LOC124637874, transcript variant X1
uncharacterized LOC124637874, transcript variant X2
uncharacterized LOC124637874, transcript variant X3
uncharacterized protein LOC124637874 isoform X1
uncharacterized protein LOC124637874 isoform X2
uncharacterized protein LOC124637874 isoform X3
secretory phospholipase A2 receptor-like
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine-enriched protein, transcript variant X2
serine-enriched protein, transcript variant X1
proline-rich receptor-like protein kinase PERK2
putative polypeptide N-acetylgalactosaminyltransferase 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X2
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X4
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X3
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X1
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X3
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X2
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X1
uncharacterized protein LOC124637720 isoform X2
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
PAN2-PAN3 deadenylation complex catalytic subunit PAN2, transcript variant X1
PAN2-PAN3 deadenylation complex catalytic subunit PAN2, transcript variant X2
PAN2-PAN3 deadenylation complex catalytic subunit PAN2, transcript variant X4
PAN2-PAN3 deadenylation complex catalytic subunit PAN2, transcript variant X3
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X4
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X3
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X2
PAN2-PAN3 deadenylation complex catalytic subunit PAN2 isoform X1
uncharacterized LOC124637822, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC124637822 isoform X1
uncharacterized LOC124637822, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC124637822 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124637578, transcript variant X1
uncharacterized LOC124637578, transcript variant X10
uncharacterized LOC124637578, transcript variant X11
uncharacterized LOC124637578, transcript variant X5
uncharacterized LOC124637578, transcript variant X4
uncharacterized LOC124637578, transcript variant X6
uncharacterized LOC124637578, transcript variant X9
uncharacterized LOC124637578, transcript variant X8
uncharacterized LOC124637578, transcript variant X7
uncharacterized LOC124637578, transcript variant X2
uncharacterized LOC124637578, transcript variant X3
uncharacterized protein LOC124637578 isoform X8
uncharacterized protein LOC124637578 isoform X4
uncharacterized protein LOC124637578 isoform X2
uncharacterized protein LOC124637578 isoform X9
uncharacterized protein LOC124637578 isoform X6
uncharacterized protein LOC124637578 isoform X3
uncharacterized protein LOC124637578 isoform X1
uncharacterized protein LOC124637578 isoform X5
uncharacterized protein LOC124637578 isoform X7
17-beta-hydroxysteroid dehydrogenase 14-like
uncharacterized oxidoreductase YxbG-like
uncharacterized oxidoreductase TM_0325-like
POU domain, class 6, transcription factor 2, transcript variant X1
POU domain, class 6, transcription factor 2, transcript variant X5
POU domain, class 6, transcription factor 2, transcript variant X4
POU domain, class 6, transcription factor 2, transcript variant X10
POU domain, class 6, transcription factor 2, transcript variant X3
POU domain, class 6, transcription factor 2, transcript variant X6
POU domain, class 6, transcription factor 2, transcript variant X8
POU domain, class 6, transcription factor 2, transcript variant X2
POU domain, class 6, transcription factor 2, transcript variant X7
POU domain, class 6, transcription factor 2, transcript variant X9
POU domain, class 6, transcription factor 2 isoform X1
POU domain, class 6, transcription factor 2 isoform X4
POU domain, class 6, transcription factor 2 isoform X3
POU domain, class 6, transcription factor 1 isoform X7
POU domain, class 6, transcription factor 2 isoform X2
POU domain, class 6, transcription factor 2 isoform X5
POU domain, class 6, transcription factor 2 isoform X6
POU domain, class 6, transcription factor 2, transcript variant X11
POU domain, class 6, transcription factor 2 isoform X8
tyrosine-protein phosphatase non-receptor type 4
vascular endothelial growth factor receptor 1-like, transcript variant X1
vascular endothelial growth factor receptor 1-like isoform X1
vascular endothelial growth factor receptor 1-like, transcript variant X2
vascular endothelial growth factor receptor 1-like isoform X2
glycine-rich cell wall structural protein-like
BMP and activin membrane-bound inhibitor homolog
4-hydroxyphenylpyruvate dioxygenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 605-like, transcript variant X4
zinc finger protein 605-like, transcript variant X3
zinc finger protein 605-like, transcript variant X2
zinc finger protein 605-like, transcript variant X1
protein yippee-like, transcript variant X2
protein yippee-like, transcript variant X3
protein yippee-like, transcript variant X1
protein yippee-like, transcript variant X5
protein yippee-like, transcript variant X4
26S proteasome non-ATPase regulatory subunit 11
WAS/WASL-interacting protein family member 2-like
BUB3-interacting and GLEBS motif-containing protein ZNF207, transcript variant X1
BUB3-interacting and GLEBS motif-containing protein ZNF207, transcript variant X2
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X2
BUB3-interacting and GLEBS motif-containing protein ZNF207 isoform X1
putative inorganic phosphate cotransporter, transcript variant X2
putative inorganic phosphate cotransporter isoform X2
putative inorganic phosphate cotransporter, transcript variant X1
putative inorganic phosphate cotransporter isoform X1
DNA-directed RNA polymerase I subunit RPA1
tetratricopeptide repeat protein 36 homolog
protein kinase C, brain isozyme, transcript variant X1
protein kinase C, brain isozyme, transcript variant X2
protein kinase C, brain isozyme isoform X1
protein kinase C, brain isozyme isoform X2
rac GTPase-activating protein 1-like, transcript variant X1
rac GTPase-activating protein 1-like, transcript variant X2
rac GTPase-activating protein 1-like isoform X1
rac GTPase-activating protein 1-like isoform X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X2
peroxisomal membrane protein PEX14, transcript variant X1
peroxisomal membrane protein PEX14 isoform X1
peroxisomal membrane protein PEX14, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
peroxisomal membrane protein PEX14 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RING finger protein nhl-1, transcript variant X2
RING finger protein nhl-1, transcript variant X4
RING finger protein nhl-1, transcript variant X1
RING finger protein nhl-1, transcript variant X3
calmodulin-binding transcription activator 1, transcript variant X2
calmodulin-binding transcription activator 1, transcript variant X1
calmodulin-binding transcription activator 2 isoform X2
calmodulin-binding transcription activator 1 isoform X1
UDP-xylose and UDP-N-acetylglucosamine transporter
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
CTD nuclear envelope phosphatase 1 homolog
mRNA-decapping enzyme 1A, transcript variant X1
mRNA-decapping enzyme 1A, transcript variant X2
trifunctional purine biosynthetic protein adenosine-3, transcript variant X2
trifunctional purine biosynthetic protein adenosine-3, transcript variant X1
trifunctional purine biosynthetic protein adenosine-3 isoform X1
trifunctional purine biosynthetic protein adenosine-3 isoform X2
ankyrin repeat domain-containing protein 13D
POU domain, class 3, transcription factor 3-like
phosphatidylinositol-glycan biosynthesis class X protein
myosin heavy chain, muscle, transcript variant X11
myosin heavy chain, muscle, transcript variant X10
myosin heavy chain, muscle, transcript variant X8
myosin heavy chain, muscle, transcript variant X15
myosin heavy chain, muscle, transcript variant X30
myosin heavy chain, muscle, transcript variant X16
myosin heavy chain, muscle, transcript variant X37
myosin heavy chain, muscle, transcript variant X22
myosin heavy chain, muscle, transcript variant X29
myosin heavy chain, muscle, transcript variant X23
myosin heavy chain, muscle, transcript variant X24
myosin heavy chain, muscle, transcript variant X26
myosin heavy chain, muscle, transcript variant X27
myosin heavy chain, muscle, transcript variant X6
myosin heavy chain, muscle, transcript variant X2
myosin heavy chain, muscle, transcript variant X21
myosin heavy chain, muscle, transcript variant X31
myosin heavy chain, muscle, transcript variant X5
myosin heavy chain, muscle, transcript variant X34
myosin heavy chain, muscle, transcript variant X1
myosin heavy chain, muscle, transcript variant X28
myosin heavy chain, muscle, transcript variant X12
myosin heavy chain, muscle, transcript variant X13
myosin heavy chain, muscle, transcript variant X14
myosin heavy chain, muscle, transcript variant X17
myosin heavy chain, muscle, transcript variant X18
myosin heavy chain, muscle, transcript variant X9
myosin heavy chain, muscle, transcript variant X36
myosin heavy chain, muscle, transcript variant X4
myosin heavy chain, muscle, transcript variant X19
myosin heavy chain, muscle, transcript variant X20
myosin heavy chain, muscle, transcript variant X3
myosin heavy chain, muscle, transcript variant X35
myosin heavy chain, muscle, transcript variant X7
myosin heavy chain, muscle, transcript variant X32
myosin heavy chain, muscle, transcript variant X25
myosin heavy chain, muscle, transcript variant X33
multiple inositol polyphosphate phosphatase 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
probable ATP-dependent RNA helicase DDX56
E3 ubiquitin-protein ligase Ubr3, transcript variant X3
E3 ubiquitin-protein ligase Ubr3, transcript variant X1
E3 ubiquitin-protein ligase Ubr3, transcript variant X2
E3 ubiquitin-protein ligase Ubr3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
E3 ubiquitin-protein ligase Ubr3 isoform X2
E3 ubiquitin-protein ligase Ubr3 isoform X1
E3 ubiquitin-protein ligase Ubr3 isoform X3
uncharacterized LOC124637773, transcript variant X1
uncharacterized LOC124637773, transcript variant X2
uncharacterized LOC124637773, transcript variant X3
uncharacterized LOC124637773, transcript variant X4
uncharacterized protein LOC124637773 isoform X1
uncharacterized protein LOC124637773 isoform X2
uncharacterized protein LOC124637773 isoform X3
uncharacterized protein LOC124637773 isoform X4
uncharacterized LOC124637624, transcript variant X1
uncharacterized LOC124637624, transcript variant X2
uncharacterized protein LOC124637624 isoform X1
uncharacterized protein LOC124637624 isoform X2
cationic amino acid transporter 2-like, transcript variant X1
cationic amino acid transporter 2-like isoform X1
cationic amino acid transporter 2-like, transcript variant X3
cationic amino acid transporter 2-like isoform X3
cationic amino acid transporter 2-like, transcript variant X2
cationic amino acid transporter 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cationic amino acid transporter 3, transcript variant X2
cationic amino acid transporter 3, transcript variant X1
cationic amino acid transporter 3 isoform X1
cationic amino acid transporter 3 isoform X2
high affinity cationic amino acid transporter 1-like, transcript variant X2
high affinity cationic amino acid transporter 1-like, transcript variant X1
high affinity cationic amino acid transporter 1-like, transcript variant X3
high affinity cationic amino acid transporter 1-like isoform X1
uncharacterized protein LOC124637762 isoform X2
mediator of RNA polymerase II transcription subunit 26-like
transforming growth factor beta-1-induced transcript 1 protein, transcript variant X1
transforming growth factor beta-1-induced transcript 1 protein, transcript variant X2
transforming growth factor beta-1-induced transcript 1 protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124637348, transcript variant X3
uncharacterized LOC124637348, transcript variant X2
uncharacterized LOC124637348, transcript variant X1
uncharacterized protein LOC124637348 isoform X1
uncharacterized protein LOC124637348 isoform X3
uncharacterized protein LOC124637348 isoform X2
uncharacterized LOC124637793, transcript variant X2
uncharacterized LOC124637793, transcript variant X1
putative inorganic phosphate cotransporter
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns